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Abstract: Acne cases caused by Staphylococcus epidermidis bacteria have been reported previously. This study identified 
methicillin resistant Staphylococcus epidermidis (MRSE) directly from pus speciment from acne patients at various degree of 
severity. There were 61% positive samples detected by Polymerase Chain Reaction (PCR) for MRSE using target gene mecA 
for PCR amplification of acne samples. Significant correlation between the severity of acne and its causative agent (MRSE) 
was not found. 
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1. Introduction 
Humans are colonized by many different staphylococcal 
species. Members of the genus Staphylococcus are common 
colonizers of the skin. Two main groups are distinguished by 
their ability to coagulate blood: coagulase-positive 
Staphylococci, with the most important species being 
Staphylococcus aureus, and coagulase-negative 
staphylococci, which comprise most species including 
Staphylococcus epidermidis. The largest density of 
staphylococci is found in sweat glands and on mucous 
membranes surrounding body openings [1]. 
While S. epidermidis is commensal on the skin, it is 
considered a pathogen if it breaches the skin surface and 
enters the bloodstream [2]. S. epidermidis is the 
staphylococcal species that is most frequently isolated from 
the human skin. It predominantly colonizes the nose, axillae 
and the head [1]. S. epidermidis, which are normal 
inhabitants of the skin, were isolated from acne vulgaris 
inflammatory sites of patients [3]. 
Acne vulgaris is a chronic inflammatory disorder of 
pilosebaceous follicles that affects more than 85 percent of 
adolescents and young adults. Four major factors are 
involved in the pathogenesis including increased sebum 
production, hypercornification of the pilosebaceous duct, an 
abnormality of the microbial flora especially colonization of 
the duct, and the production of inflammation. Several factors 
that may influence acne include diet, menstruation cycle, 
sweating, stress, ultra violet radiation and occupation [4]. 
An acne lesion, particularly a closed comedone or deep-
seated abscess in an open comedone, creates an anaerobic 
microenvironment which facilitates overgrowth of 
Propionibacterium acnes (P. acnes). It has been reported that 
P. acnes, S. epidermidis, and other skin microflora co-exist in 
acne lesions [5]. Although acne is not considered an 
infectious disease, three major organisms were isolated from 
the surface of the skin and the pilosebaceous duct of patients 
with acne including P. acne, S. epidermidis and Malasezia 
furfur. Depending on the severity of the disease, acne 
patients receive topical or systemic antibiotic therapy, or a 
combination [4]. 
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Antibiotic resistance is frequent in many staphylococci and 
significantly complicates and increases the cost of treatment 
[1]. The development of accurate and simple methods to 
identify isolates of S. epidermidis and determine their 
methicillin resistance is important to establish the clinical 
relevance of S. epidermidis [6]. 
The emergence of S. epidermidis as an opportunistic 
pathogen is very critical. While anti-staphylococcal 
penicillins such as methicillin and oxacillin were considered 
as the first-line therapy options, the emergence of 
methicillin-resistant Staphylococci have impacted the 
concerns in healthcare units [7]. 
S. epidermidis on the skin may cause an opportunistic 
infection and also has the potential to become a reservoir of 
antimicrobial resistance genes; methicillin resistance gene 
(mecA). A previous study investigated the antimicrobial 
susceptibilities of P. acnes and S. epidermidis isolated from 
patients with acne vulgaris in a university hospital in Japan 
from 1996 to 1997. At that time, no antimicrobial-resistant 
strains were found for P. acnes, and S. epidermidis showed a 
high susceptibility to antimicrobials [3]. Methicillin-resistant 
staphylococcal strains acquired and integrated into their 
genome the staphylococcal cassette chromosome mec 
(SCCmec), which carries the methicillin resistance (mecA) 
gene encoding for an altered penicillin binding protein, and 
other antibiotic resistance determinants [8]. 
Resistance to methicillin was reported for the first time in 
1961. In a study which was conducted by Guisti et al. in 
1999, methicillin resistance ratio was reported (48.6%). 
Resistance to mentioned antimicrobial groups has been even 
more increasing, for instance in Finland in 1983 the 28% 
resistance was raised up to 77% in 1994. Currently 75 up to 
90% of S. epidermidis isolates from various nosocomial 
infections in most European and American countries are 
methicillin-resistant strains [7]. 
Concordant with the increment of coagulase-negative 
Staphylococci importance particularly S. epidermidis as an 
agent of nosocomial infections, further clinical and 
experimental studies in different fields such as mechanism of 
transmission, ecology, virulence factors, typing methods and 
antimicrobial resistance mechanism are needed. The 
prevention and treatment of S. epidermidis infections should 
depend on our knowledge about the reservoirs, epidemiology, 
and host defenses against these microorganisms [7]. Thus 
this paper aimed to present the identification of methicillin 
resistant Staphylococcus epidermidis in acne of patients with 
different levels of severity. 
2. Materials and Methods 
A total of 46 females who met the criteria of acne vulgaris 
with degree of acne ranging from mild, moderate and severe 
attending Wahidin Sudirohusodo hospital, Hasanuddin 
University hospital and among senior high school students in 
the city of Makassar were studied. The research was 
conducted by examining clinical manifestations and sebum 
levels. Specimens were obtained from comedonal lesions, 
papulopustular lesions, or nodular lesions at the facial area, 
the number of papul or pustul were counted and used to 
determine the classification of mild, moderate and severe 
acne based on combined acne severity classification. PCR 
technique was performed in order to detect the presence of 
Methicillin-resistant Staphylococcus epidermidis. Prior to 
sampling, the subjects had signed informed consent. 
2.1. Materials 
Primers used in this study were MRS1 (5’-TAG AAA 
TGA CTG AAC GTC CG-3’) and MRS2 (5’-TTG CGA 
TCA ATG TTA CCG TAG-3’). Go taq Master Mix Green, 
Hot Star Taq DNA polymerase 0.5 TAE buffer, and 100 base 
pair DNA ladder were used. The PCR results were validated 
with a clinically relevant strain isolated from acne lession. 
The samples were taken each with sterile swabs placed in 
Phosphate Buffered Solution (PBS) and brought to the 
Microbiology Laboratory of Hasanuddin University Hospital. 
All samples were kept at -20
o
C until ready for PCR 
examination.  
2.2. PCR Method 
DNA extraction from swab samples was performed 
according to the methods recommended by Geneaid. Initially 
S2 solution was prepared by adding 1µl RNA Carrier with 
500µl S2 buffer to each samples. Into the swab samples, 500 
µl of S1 solution and 20 µl Proteinase K was added, vortexed 
for ten seconds and incubated at 60°C for 10 minutes. Each 
sample were then transferred to column filter on 1.5 ml 
microtube, sentrifuged at 14000-16000 (15000) X g for two 
minutes. The filter column was then removed. After adding 
500 µl of S2 solution, vortexed, incubated at 60°C for ten 
minutes including vortexing every 5 minutes, 500 µl Ethanol 
Absolute was added and mixed for ten seconds. The solution 
was transferred 750 µl into GD Column on 2 ml collection 
tube, sentrifuged at 14000-16000 (15000) X g for one minute. 
This process was repeated once more, then the collection 
tube was discarded, and replaced with a new 2ml collection 
tube. 
Washing: Buffer W1 400 ul was added into the GD 
column, centrifuged at 14000-16000 (15000) X g for 30 
seconds, then liquid contained in the collection tube was 
discarded. After adding 600 ul Wash Buffer (previously was 
added 100 ml Ethanol), tube was centrifuged at 14000-16000 
(15000) X g for 30 seconds. The liquid contained in the 
collection tube was discarded and centrifuged again at a 
speed of 14000-16000 (15000) X g for 3 minutes. 
Elution: the GD column was transferred on 1.5 ml 
microtube, previously heated elution buffer was added 100 ul, 
and allowed to stand for 3 minutes before centrifuged 
at14000- 16000 (15000) X g for five minutes. The GD 
column was discarded and the liquid contained in the 
microtube contained the DNA ready to be tested for PCR.  
2.3. Amplification 
The amplification was performed on a Thermal Cycler 
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(Mastercycler, Eppendorf, Hamburg, Germany) using 25 µl 
of PCR mixture containing 12.5 µl of master mix green, 0.5 
µl of Forward Primer, 0.5 µl of Reverse Primer, 6.5 µl 
Nuclease Free Water, and 5 µl DNA product. Amplification 
were performed under these conditions: denaturation for 3 
min at 94°C, followed by 30 cycles of 94°C for 1 min, 58°C 
for 1 min and 72°C for 1min, with final extension at 72°C for 
5 minutes. Amplified products were analyzed using 1.5% of 
agarose gel electrophoresis with GelRed 1X (Biotium, 
California, USA), visualized and captured on UV 
transilluminator (Mini BIS Pro, DNR Bio Imaging Systems, 
Jerusalem, Israel). 
3. Results 
Table 1. PCR Results on 46 acne samples at various level of severity. 
Degree of Acne 
MRSE 
Total 
X2 p = 0,869 
+ - 
Mild 9 (19,6) 6 (13,0) 15 
Moderate 10 (21,7) 6 (13,0) 16 
Severe 9 (19,6) 6 (13,0) 15 
Total 28 (61,0) 18 (39,0) 46 
From the table above we can see that more than half of the study subjects with acne (61,0%) were infected with S. 
epidermidis which were MRSE. It is consistent with the theory that acne vulgaris patient should not be given MRSE class 
antibiotics because they contained bacteria which are already resistant. However the positivity of MRSE on different severity 
of acne did not differ significantly (p> 0.05), meaning that in all patients with acne vulgaris regardless of its degree of severity, 
should not be given antibiotics of the MRSE class. 
 
Figure 1. Methicillin-resistant Staphylococcus epidermidis PCR result among severe acne group. 
Figure 1 showed that there were 9 positive samples and 6 negative samples in MRSE PCR among samples with severe acne. 
 
Figure 2. Methicillin-resistant Staphylococcus epidermidis PCR result among moderate acne group. 
Figure 2 showed that there were 10 positive samples and 6 negative samples in MRSE PCR among moderate acne group. 
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Figure 3. Methicillin-resistant Staphylococcus epidermidis PCR result among mild acne group 
Figure 3 showed that there are 9 positive samples and 6 
negative samples in MRSE PCR result in mild acne group. 
4. Discussion 
Staphylococcus epidermidis (S. epidermidis) is a common 
commensal bacterium of the human skin and mucosa. While 
S. epidermidis has long been considered nonpathogenic, it is 
now recognized as a relevant opportunistic pathogen [9]. 
Understanding the patterns of resistance and tolerance of 
S. epidermidis to antimicrobial agents is essential for the 
appropriate diagnosis and management of S. epidermidis 
infections. Antibiotic resistance patterns might be useful in 
differentiating a nosocomial isolate from a community-
acquired isolate. S. epidermidis is one of the leading 
nosocomial organisms with a characteristic multidrug-
resistant pattern, including resistance to methicillin [10]. 
The increasing antibiotic resistance of nosocomial isolates 
of S. epidermidis poses a great challenge for the management 
of hospital-acquired infections in general. Worldwide 
surveillance shows that the isolation frequency of 
methicillinresistant S. epidermidis (MRSE) can reach 80% in 
hospitals [2]. 
S. epidermidis is one of the normal inhabitants of the skin 
and easily acquires and transmits the various antimicrobial 
resistance genes [3]. Methicillin resistance is frequently 
found also in S. epidermidis, and may originally have been 
transferred to S. aureus from this species [1]. 
Molecular factors that determine staphylococcal 
pathogenesis have been extensively investigated. Aggressive 
virulence determinants such as toxins are mostly found in S. 
aureus, while other species mostly lack the production of 
toxins. Interestingly, in S. epidermidis as the most intensively 
studied species other than S. aureus, for the most part, factors 
that have been implicated in pathogenesis appear to have 
original functions in the noninfectious lifestyle of this 
bacterium. This indicates that these less aggressive species 
have not evolved to become pathogenic, but infection has to 
be regarded as an ‘accident’ rather than a program [11]. 
The accidental nature of infection with species such as S. 
epidermidis suggests that the frequency of infections is to a 
large part determined by the abundance of these species on 
the human body, from where infection is believed to 
originate. The most important sources of infection with S. 
epidermidis and many other staphylococci are likely the skin 
and mucous membranes of patients or healthcare personnel 
[11]. 
This study found 61.0% MRSE resistance in acne infected 
with staphylococcus epidermidis. Although the history of 
antibiotic use was not known among these patients, the 
prevalence of those antimicrobial resistance genes in S. 
epidermidis may be caused by the previous use of 
clindamycin and gentamicin in treating skin and soft tissue 
infections. The pathogenicity of S. epidermidis for acne 
vulgaris remains unclear and is assumed that S. epidermidis 
could become a reservoir of various antimicrobial resistance 
genes on the skin [3]. 
Based on a suggestion from a study by Keisuke et al, the 
existence of antimicrobial-resistant bacteria should be 
considered when selecting antimicrobial therapy for 
inflammatory acne, and antimicrobials should not be used for 
the maintenance therapy of acne vulgaris [3]. This suggestion 
is appropriate with the finding in our study. 
5. Conclusion 
Simple PCR identified MRSE from pus speciment of acne 
patients at various levels of severity, however the level of 
severity of acne has no significant correlation with the 
presence of MRSE. Acne vulgaris patient should not be 
given MRSE class antibiotics because they contained 
bacteria which are already resistant, meaning that all patients 
with acne vulgaris regardless of its degree of severity, should 
not be given antibiotics for maintenance therapy. 
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